Denmark Intravenous Solutions Market Size & Outlook
Related Markets
Denmark intravenous solutions market highlights
- The Denmark intravenous solutions market generated a revenue of USD 70.1 million in 2023 and is expected to reach USD 120.0 million by 2030.
- The Denmark market is expected to grow at a CAGR of 8% from 2024 to 2030.
- In terms of segment, total parenteral nutrition was the largest revenue generating product in 2023.
- Total Parenteral Nutrition is the most lucrative product segment registering the fastest growth during the forecast period.
Intravenous solutions market data book summary
| Market revenue in 2023 | USD 70.1 million |
| Market revenue in 2030 | USD 120.0 million |
| Growth rate | 8% (CAGR from 2023 to 2030) |
| Largest segment | Total parenteral nutrition |
| Fastest growing segment | Total Parenteral Nutrition |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Total Parenteral Nutrition, Peripheral Parenteral Nutrition |
| Key market players worldwide | Fresenius SE & Co KGaA, Fresenius Kabi, Pfizer Inc, Otsuka Pharmaceutical, Baxter International Inc, B. Braun, JW Life Sciences, CSL Ltd |
Other key industry trends
- In terms of revenue, Denmark accounted for 0.5% of the global intravenous solutions market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany intravenous solutions market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 2,011.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Intravenous Solutions Market Scope
Intravenous Solutions Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| JW Life Sciences | View profile | - | Yangjin, Kyonggi-do, South Korea, Asia | http://jw-lifescience.co.kr/lifescience/ko/main.jsp |
| Fresenius Kabi | View profile | 1001-5000 | Gurgaon, Haryana, India, Asia | https://www.fresenius-kabi-oncology.com/ |
| CSL Ltd | View profile | 32000 | 655 Elizabeth Street, Melbourne, VIC, Australia, 3000 | https://www.csl.com |
| Otsuka Pharmaceutical | View profile | 251-500 | Tokyo, Tokyo, Japan, Asia | https://www.otsuka.co.jp/en/ |
| B. Braun | View profile | 10001+ | Chapeltown, Sheffield, United Kingdom, Europe | https://www.bbraun.co.uk |
| Fresenius SE & Co KGaA | View profile | 193865 | Else-Kroener-Strasse 1, Bad Homburg, HE, Germany, 61352 | https://www.fresenius.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Baxter International Inc | View profile | 60000 | One Baxter Parkway, Deerfield, IL, United States, 60015 | https://www.baxter.com |
Denmark intravenous solutions market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intravenous solutions market will help companies and investors design strategic landscapes.
Total parenteral nutrition was the largest segment with a revenue share of 65.91% in 2023. Horizon Databook has segmented the Denmark intravenous solutions market based on total parenteral nutrition, peripheral parenteral nutrition covering the revenue growth of each sub-segment from 2018 to 2030.
The Denmark intravenous solutions market has witnessed steady growth in the previous years, driven by factors such as the increasing prevalence of chronic diseases, rapidly aging population, and advancements in healthcare infrastructure.
Moreover, the growing awareness about the benefits of intravenous therapy and the availability of a wide range of products have contributed to market expansion. Moreover, technological advancements in drug delivery systems and a shift toward personalized medicine have fueled the market growth.
Key players in the Denmark intravenous solutions market have been investing in R&D activities to introduce innovative products with improved safety and efficacy profiles. The market has witnessed a surge in the adoption of integrated Electronic Health Record (EHR) systems, facilitating efficient management of intravenous therapy and improving patient outcomes.
Reasons to subscribe to Denmark intravenous solutions market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Denmark intravenous solutions market databook
-
Our clientele includes a mix of intravenous solutions market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Denmark intravenous solutions market , including forecasts for subscribers. This country databook contains high-level insights into Denmark intravenous solutions market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Denmark intravenous solutions market size, by product, 2018-2030 (US$M)
Denmark Intravenous Solutions Market Outlook Share, 2023 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
